<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Archives des Technological and digital innovation - OncoSTART</title>
	<atom:link href="https://oncostart.fr/places/category/technological-and-digital-innovation/feed/" rel="self" type="application/rss+xml" />
	<link>https://oncostart.fr/places/category/technological-and-digital-innovation/</link>
	<description>Entreprendre contre le cancer</description>
	<lastBuildDate>Tue, 11 Jul 2023 10:00:53 +0000</lastBuildDate>
	<language>fr-FR</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>AMKbiotech</title>
		<link>https://oncostart.fr/places/amkbiotech/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=amkbiotech</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Fri, 17 Mar 2023 13:14:25 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=1992</guid>

					<description><![CDATA[<p>AMKbiotech is a CRO providing the biomedical research actors with a specialized expertise and tailored end-to-end HIGH-PLEX TISSUE IMAGING and CYTOMETRY services Contact contact@amkbiotech.fr &#160; Address 2400 Route des Colles 06410 Biot &#160; Contact www.amkbiotech.fr</p>
<p>L’article <a href="https://oncostart.fr/places/amkbiotech/">AMKbiotech</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>AMKbiotech is a CRO providing the biomedical research actors with a specialized expertise and tailored end-to-end HIGH-PLEX TISSUE IMAGING and CYTOMETRY services</p>
<p><strong>Contact</strong></p>
<p>contact@amkbiotech.fr</p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p>2400 Route des Colles 06410 Biot</p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="http://www.amkbiotech.fr" target="_blank" rel="noopener">www.amkbiotech.fr</a></p>
<p>L’article <a href="https://oncostart.fr/places/amkbiotech/">AMKbiotech</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>AVATAR MEDICAL</title>
		<link>https://oncostart.fr/places/avatar-medical/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=avatar-medical</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Thu, 10 Jun 2021 15:04:23 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=998</guid>

					<description><![CDATA[<p>Presentation AVATAR MÉDICAL enables surgeons to better prepare their surgical strategy, by converting standard medical images (scanner and MRI) in real time into interactive 3D avatars which can be navigated in virtual reality. AVATAR MEDICAL is a spin-off of the Institut Pasteur and the Institut...</p>
<p>L’article <a href="https://oncostart.fr/places/avatar-medical/">AVATAR MEDICAL</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p>AVATAR MÉDICAL enables surgeons to better prepare their surgical strategy, by converting standard medical images (scanner and MRI) in real time into interactive 3D avatars which can be navigated in virtual reality.</p>
<p>AVATAR MEDICAL is a spin-off of the Institut Pasteur and the Institut Curie, benefiting from four years of advanced research in computer vision and AI.</p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p>contact@avatarmedical.ai</p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p>11 Rue de Lourmel, 75015 Paris</p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p><a href="https://avatarmedical.ai/" target="_blank" rel="noopener">https://avatarmedical.ai/</a></p>
<p>&nbsp;</p>
<p class="p2"><b>Targeting innovation</b> : Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Stomach cancer, Liver cancer, Head and neck cancers, Gastrointestinal cancers, Gynecological cancers, Bone cancer</p>
<p>&nbsp;</p>
<p>L’article <a href="https://oncostart.fr/places/avatar-medical/">AVATAR MEDICAL</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Beams</title>
		<link>https://oncostart.fr/places/beams/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=beams</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Fri, 17 Mar 2023 14:04:04 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=1997</guid>

					<description><![CDATA[<p>BEAMS développe une sonde peropératoire pour les aider les chirurgiens à localiser précisément et en temps réel les potentiels résidus tumoraux et les retirer sans endommager les tissus sains environnants. Pour cela, Beams couple au sein du même outil une fonctionnalité de détection de radiotraceurs...</p>
<p>L’article <a href="https://oncostart.fr/places/beams/">Beams</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p style="text-align: justify;">BEAMS développe une sonde peropératoire pour les aider les chirurgiens à localiser précisément et en temps réel les potentiels résidus tumoraux et les retirer sans endommager les tissus sains environnants. Pour cela, Beams couple au sein du même outil une fonctionnalité de détection de radiotraceurs émetteurs β commerciaux et un dispositif d’aide à la chirurgie (aspiration des tissus mous) ; l’enjeu est de réduire le risque de récidive locale et de préserver la qualité de vie des patients.</p>
<p><strong>Contact</strong></p>
<p>contact@beams.bio</p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p>30/32 Boulevard de Sébastopol, 75004 Paris</p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="http://www.beams.bio" target="_blank" rel="noopener">www.beams.bio</a></p>
<p>&nbsp;</p>
<p class="p1"><b>Targeted indications</b> : Liver cancer, Brain cancer</p>
<p>L’article <a href="https://oncostart.fr/places/beams/">Beams</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>BIOSITECH</title>
		<link>https://oncostart.fr/places/biositech/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biositech</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Fri, 05 May 2023 10:08:56 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=2191</guid>

					<description><![CDATA[<p>Contact: Julien DUMAS j.dumas@biositech.com Website: https://biositech.com/</p>
<p>L’article <a href="https://oncostart.fr/places/biositech/">BIOSITECH</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Contact: Julien DUMAS <a href="mailto:j.dumas@biositech.com" target="_blank" rel="noopener">j.dumas@biositech.com</a></p>
<p>Website: <a href="https://biositech.com/" target="_blank" rel="noopener">https://biositech.com/</a></p>
<p>L’article <a href="https://oncostart.fr/places/biositech/">BIOSITECH</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Cureety</title>
		<link>https://oncostart.fr/places/cureety/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cureety</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Sat, 17 Apr 2021 12:06:06 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=395</guid>

					<description><![CDATA[<p>Presentation Cureety, has developed and launched a digital telemonitoring platform for the follow-up of patients with cancer and with chronic diseases, with three main goals: 1. Accompany the patients on their care pathway and improve their lives. 2. Assist caregivers and optimize their work. 3....</p>
<p>L’article <a href="https://oncostart.fr/places/cureety/">Cureety</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;Cureety, has developed and launched a digital telemonitoring platform for the follow-up of\npatients with cancer and with chronic diseases, with three main goals:\n\n1. Accompany the patients on their care pathway and improve their lives.\n2. Assist caregivers and optimize their work.\n3. Bring clinicians and pharma an innovative solution for collecting\nhigh-quality real-world data on the diseases and their treatments.&quot;}" data-sheets-userformat="{&quot;2&quot;:513,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0}">Cureety, has developed and launched a digital telemonitoring platform for the follow-up of<br />
patients with cancer and with chronic diseases, with three main goals:</span></p>
<p>1. Accompany the patients on their care pathway and improve their lives.<br />
2. Assist caregivers and optimize their work.<br />
3. Bring clinicians and pharma an innovative solution for collecting<br />
high-quality real-world data on the diseases and their treatments.</p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="mailto:francois@cureety.com"><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;francois@cureety.com&quot;}" data-sheets-userformat="{&quot;2&quot;:513,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0}">francois@cureety.com</span></a></p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;33 rue de l'amirauté, 22100 Dinan &quot;}" data-sheets-userformat="{&quot;2&quot;:2817,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}">33 rue de l&rsquo;amirauté, 22100 Dinan </span></p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p><a href="https://www.cureety.com" target="_blank" rel="noopener">https://www.cureety.com</a></p>
<p>&nbsp;</p>
<p class="p2"><b>Targeted indications</b> : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head &amp; neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.</p>
<p>L’article <a href="https://oncostart.fr/places/cureety/">Cureety</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Deeplink Medical</title>
		<link>https://oncostart.fr/places/deeplink-medical/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=deeplink-medical</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Sat, 17 Apr 2021 12:27:16 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=405</guid>

					<description><![CDATA[<p>Presentation Deeplink Medical is a company specializing in the development of (tele) medicine software for healthcare professionals. On the initiative of 5 radiologists, Deeplink Medical builds its solutions by combining in-depth medical thinking and solid technology, supported by in-house multidisciplinary teams. Present in more than...</p>
<p>L’article <a href="https://oncostart.fr/places/deeplink-medical/">Deeplink Medical</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;Deeplink Medical is a company specializing in the development of (tele) medicine software for healthcare professionals.\r\nOn the initiative of 5 radiologists, Deeplink Medical builds its solutions by combining in-depth medical thinking and solid technology, supported by in-house multidisciplinary teams.\r\nPresent in more than 100 healthcare establishments, Deeplink Medical is part of two major therapeutic areas, radiology and oncology.&quot;}" data-sheets-userformat="{&quot;2&quot;:2817,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:9961472}}">Deeplink Medical is a company specializing in the development of (tele) medicine software for healthcare professionals.<br />
On the initiative of 5 radiologists, Deeplink Medical builds its solutions by combining in-depth medical thinking and solid technology, supported by in-house multidisciplinary teams.<br />
Present in more than 100 healthcare establishments, Deeplink Medical is part of two major therapeutic areas, radiology and oncology.</span></p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="mailto:communication@deeplink-medical.com"><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;communication@deeplink-medical.com&quot;}" data-sheets-userformat="{&quot;2&quot;:513,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0}">communication@deeplink-medical.com</span></a></p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;22 rue seguin, 69003 Lyon&quot;}" data-sheets-userformat="{&quot;2&quot;:2817,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}">22 rue seguin, 69003 Lyon</span></p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p>deeplink-medical.com</p>
<p>&nbsp;</p>
<p class="p1"><b>Targeted indications</b> : Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Stomach cancer, Liver cancer, Brain cancer, Head and neck cancers, Gastrointestinal cancers, Gynecological cancers, Bone cancer, Genitourinary cancers, Skin cancer</p>
<p>L’article <a href="https://oncostart.fr/places/deeplink-medical/">Deeplink Medical</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>DREAMER</title>
		<link>https://oncostart.fr/places/dreamer/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dreamer</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Mon, 15 Nov 2021 10:08:33 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=1318</guid>

					<description><![CDATA[<p>Presentation DREAMER is a medical device that fights the scar rigidity induced by mastectomy after a breast cancer, thereby increasing the possibilities of using breast reconstruction by injection, which is less invasive and less dangerous than other methods currently proposed. Contact dreamer-paris@outlook.fr &#160; Address 4...</p>
<p>L’article <a href="https://oncostart.fr/places/dreamer/">DREAMER</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation </strong></p>
<p>DREAMER is a medical device that fights the scar rigidity induced by mastectomy after a breast cancer, thereby increasing the possibilities of using breast reconstruction by injection, which is less invasive and less dangerous than other methods currently proposed.</p>
<pre id="tw-target-text" class="tw-data-text tw-text-large XcVN5d tw-ta" dir="ltr" data-placeholder="Traduction"></pre>
<p><strong>Contact</strong></p>
<p>dreamer-paris@outlook.fr</p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<div class="desktop-title-content">4 rue Maurice Bouchor &#8211; Hall 22 &#8211; 75014 PARIS</div>
<div></div>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p class="p2"><b>Targeting indications</b> :</p>
<p>All</p>
<p>L’article <a href="https://oncostart.fr/places/dreamer/">DREAMER</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dyameo</title>
		<link>https://oncostart.fr/places/dyameo/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=dyameo</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Wed, 07 Apr 2021 12:53:07 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=300</guid>

					<description><![CDATA[<p>Presentation Dyameo offers an instantaneous and new approach for cancer cells detection. Located at the end of a few millimetres diameter optical fiber, our tool facilitates the diagnosis by analysing the patient&#8217;s tissue in real time. Dyameo&#8217;s technology is based on a platform of innovative...</p>
<p>L’article <a href="https://oncostart.fr/places/dyameo/">Dyameo</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p>Dyameo offers an instantaneous and new approach for cancer cells detection. Located at the end of a few millimetres diameter optical fiber, our tool facilitates the diagnosis by analysing the patient&rsquo;s tissue in real time. Dyameo&rsquo;s technology is based on a platform of innovative patented biosensors allowing the ultra fast detection of biomarkers or other molecules. The first targeted application is the delimitation of the resection margins during oncology surgeries.</p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="contact@dyameo.com"><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;contact@dyameo.com&quot;}" data-sheets-userformat="{&quot;2&quot;:2561,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}">contact@dyameo.com</span></a></p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;1 Avenue D'ESTER 87280 LIMOGES&quot;}" data-sheets-userformat="{&quot;2&quot;:2817,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}">1 Avenue D&rsquo;ESTER 87280 LIMOGES</span></p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;www.dyameo.com&quot;}" data-sheets-userformat="{&quot;2&quot;:2561,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}" data-sheets-hyperlink="http://www.dyameo.com"><a class="in-cell-link" href="http://www.dyameo.com" target="_blank" rel="noopener">www.dyameo.com</a></span></p>
<p>&nbsp;</p>
<p class="p1"><b>Targeted indications</b> : Lung cancer, Head and neck cancers, Skin cancer</p>
<p>L’article <a href="https://oncostart.fr/places/dyameo/">Dyameo</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Epigene Labs</title>
		<link>https://oncostart.fr/places/epigene-labs/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=epigene-labs</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Thu, 06 May 2021 11:26:49 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=696</guid>

					<description><![CDATA[<p>Presentation Epigene Labs develops a data science platform for molecular and clinical data analysis in for drug discovery and translational research in oncology. &#160; Contact contact@epigenelabs.com &#160; Address 7 square Gabriel Fauré 75017 Paris &#160; Website www.epigenelabs.com &#160; Targeting innovation : breast cancer, lung cancer,...</p>
<p>L’article <a href="https://oncostart.fr/places/epigene-labs/">Epigene Labs</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;Epigene Labs develops a data science platform for molecular and clinical data analysis in for drug discovery and translational research in oncology.&quot;}" data-sheets-userformat="{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}">Epigene Labs develops a data science platform for molecular and clinical data analysis in for drug discovery and translational research in oncology.</span></p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;contact@epigenelabs.com&quot;}" data-sheets-userformat="{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}">contact@epigenelabs.com</span></p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;7 square Gabriel Fauré 75017 Paris&quot;}" data-sheets-userformat="{&quot;2&quot;:769,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0}">7 square Gabriel Fauré 75017 Paris</span></p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p><a href="https://www.epigenelabs.com/" target="_blank" rel="noopener">www.epigenelabs.com</a></p>
<p>&nbsp;</p>
<p class="p2"><b>Targeting innovation</b> : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head &amp; neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.</p>
<p>L’article <a href="https://oncostart.fr/places/epigene-labs/">Epigene Labs</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>ExactCure</title>
		<link>https://oncostart.fr/places/exactcure/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=exactcure</link>
		
		<dc:creator><![CDATA[OncoSTART]]></dc:creator>
		<pubDate>Wed, 07 Apr 2021 07:07:02 +0000</pubDate>
				<guid isPermaLink="false">https://oncostart.fr/?post_type=gd_place&#038;p=287</guid>

					<description><![CDATA[<p>Presentation ExactCure is developing a personalized health solution that helps with the correct use of medication. Our Digital Twin simulates the concentration of drugs in the blood &#160; Contact f.astic@exactcure.com &#160; Address 27 Rue du Professeur Delvalle, 06000 Nice &#160; Website www.exactcure.com &#160; Targeted indications...</p>
<p>L’article <a href="https://oncostart.fr/places/exactcure/">ExactCure</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><strong>Presentation</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;ExactCure is developing a personalized health solution that helps with the correct use of medication. Our Digital Twin simulates the concentration of drugs in the blood&quot;}" data-sheets-userformat="{&quot;2&quot;:2817,&quot;3&quot;:{&quot;1&quot;:0},&quot;11&quot;:4,&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:9961472}}">ExactCure is developing a personalized health solution that helps with the correct use of medication. Our Digital Twin simulates the concentration of drugs in the blood</span></p>
<p>&nbsp;</p>
<p><strong>Contact</strong></p>
<p><a href="mailto:f.astic@exactcure.com"><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;f.astic@exactcure.com&quot;}" data-sheets-userformat="{&quot;2&quot;:2561,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}">f.astic@exactcure.com</span></a></p>
<p>&nbsp;</p>
<p><strong>Address</strong></p>
<p>27 Rue du Professeur Delvalle, 06000 Nice</p>
<p>&nbsp;</p>
<p><strong>Website</strong></p>
<p><span data-sheets-value="{&quot;1&quot;:2,&quot;2&quot;:&quot;www.exactcure.com&quot;}" data-sheets-userformat="{&quot;2&quot;:2561,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;14&quot;:{&quot;1&quot;:2,&quot;2&quot;:65280}}" data-sheets-hyperlink="http://www.exactcure.com"><a class="in-cell-link" href="http://www.exactcure.com" target="_blank" rel="noopener">www.exactcure.com</a></span></p>
<p>&nbsp;</p>
<p class="p2"><b>Targeted indications</b> : breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, supportive care, liver cancer, brain cancer, head &amp; neck cancer, gastrointestinal cancer, gynecological cancer, bone cancer, genitourinary cancer, skin cancer, hematologic cancer, lymphoma, myeloma, leukemia, predictive toxicology.</p>
<p>L’article <a href="https://oncostart.fr/places/exactcure/">ExactCure</a> est apparu en premier sur <a href="https://oncostart.fr">OncoSTART</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
